by Jocelyn Kaiser | Nov 16, 2023 | Uncategorized
Kimryn Rathmell to become second director of the National Cancer Institute in just over 1 year
by Jocelyn Kaiser | Nov 15, 2023 | Uncategorized
Questions loom about cost, which could total millions of dollars, and who will have access
by Jocelyn Kaiser | Nov 14, 2023 | Uncategorized
Although it may not become law, measure worries microbiologists, who say it could halt low-risk research on flu vaccines and other common viruses
by Jocelyn Kaiser | Nov 11, 2023 | Uncategorized
Verve Therapeutics says its twist on CRISPR could with one treatment help prevent heart disease, a major killer, in many people
by Jocelyn Kaiser | Nov 7, 2023 | Uncategorized
After 2-year gap, biomedical research agency has a permanent chief, but she faces many challenges